Physician profile
Mark L Hagy
NPI 1235171406
$2,589.84
in general payments reported to CMS, 2019-2025
19 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $250 · 2021: $174 · 2022: $147 · 2023: $258 · 2024: $282 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.97 |
| Education | $115.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sioux Surgical INC | $991.00 | 2019 | |
| Stryker Corporation | $609.65 | 2019-2025 | Mako, T2, Variax |
| Depuy Synthes Sales INC. | $190.53 | 2019-2020 | |
| Arthrex, INC. | $153.92 | 2025 | |
| Zimmer Biomet Holdings, INC. | $115.27 | 2024 | |
| Organogenesis INC. | $63.55 | 2022 | |
| Amgen INC. | $61.33 | 2021-2024 | Prolia, Evenity |
| Pacira Pharmaceuticals Incorporated | $51.69 | 2021-2024 | Iovera |
| Hydrofera LLC | $47.78 | 2022-2023 | Hydrofera Blue |
| Rsw Medical Company, INC. | $46.48 | 2019 | |
| Paragon 28, INC. | $44.93 | 2021 | |
| Lilly USA, LLC | $34.28 | 2023 | Mounjaro, Basaglar |
| Exact Sciences Corporation | $33.12 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Vertex Pharmaceuticals Incorporated | $32.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $31.75 | 2020-2023 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $26.81 | 2019-2024 | Ozempic, Rybelsus |
| Vericel Corporation | $24.11 | 2024 | Maci |
| Pfizer INC. | $15.94 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.07 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.